Join Drs. Dimitris Kiosses and Jo Anne Sirey for a presentation on suicide prevention in older adult communities. The event will address warning signs for depression and suicide, as well as available resources for treatment. The session is free, open to the public, and is also suited for caretakers and/or patients within the older adult community who may be concerned about others.
This event is hosted both virtually on Zoom and in-person at the Weill Cornell Medicine Belfer Research Building at 413 E 69th St, New York, NY 10021. In-person seating is limited - registration for in-person attendance is strongly encouraged - walk-ins will be offered open seats approximately 2 minutes before the start of the session. Seats for walk-in attendees cannot be guarenteed. Standing will not be permitted. Light refreshments will be served. Registration for online attendance is required.
When: September 28, 2023
Where: Online (Zoom) or in-person (Belfer Research Building - 413 East 69th Street, New York, NY 10021)
Time: 1:00 PM to 2:00 PM
To attend this session via Zoom, please register here.
To attend this session in-person, please register here.
Speakers
Jo Anne Sirey, Ph.D.
Professor of Psychology in Psychiatry · Weill Cornell Medicine Profile
Dr. Sirey has expertise in developing partnerships and conducting mental health interventions in geriatric community based settings. Her research focus is on the development, implementation and impact of interventions that address psychological barriers and stigma to improve treatment engagement, treatment participation and adherence.
Dimitris Kiosses, Ph.D.
Professor of Psychology in Psychiatry · Weill Cornell Medicine Profile
Dr. Kiosses' research focuses on the development of psychosocial interventions for middle-aged and older adults with depression, suicidal ideation, chronic pain or cognitive impairment. He has developed psychosocial interventions for vulnerable patients, including patients who have been hospitalized for suicidal ideation or suicide attempt, patients with major depression and cognitive impairment, patients with negative emotions and chronic pain, and patients who have been discharged after ECT treatment.